(3.210.184.142) 您好!臺灣時間:2021/05/16 02:44
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:洪玉鳳
研究生(外文):Yu-Feng
論文名稱:龍葵水萃取物在aspirin誘導大白鼠胃黏膜損傷的預防作用
論文名稱(外文):The preventive effect of Solanum nigrum water extract in aspirin-induced rat gastric mucosa damage
指導教授:李彗禎
學位類別:碩士
校院名稱:中山醫學大學
系所名稱:生化暨生物科技研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2009
畢業學年度:97
語文別:中文
論文頁數:53
相關次數:
  • 被引用被引用:1
  • 點閱點閱:135
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
阿斯匹靈屬於非類固醇抗發炎藥的ㄧ種,會造成胃黏膜損傷,甚至引起胃、十二指腸潰瘍與其他併發症。已有研究證實活性氧自由基產生,胃黏膜的抗氧化能力減弱是造成傷害的原因之一。在先前的研究中發現龍葵成份已有多項抗氧化之報告,因此本研究目的在於如何利用龍葵水萃取物 (Solanum nigrum water extract, SNE)回復抗氧化酵素的活性而降低aspirin誘發胃黏膜損傷的風險。動物模式為以管餵預先處理SNE (100 mg/kg ;200 mg/kg ;400 mg/kg )一小時後,再管餵食200 mg/kg的aspirin,經四小時誘導Wistar大白鼠產生胃黏膜損傷。由結果發現預先處理龍葵水萃取物能降低血液中白血球的數目,也能降低胃黏膜MDA的量,同時也發現預先餵食龍葵水萃物的老鼠能回復由aspirin所減少的total GST, GST Ai, GST Pi與GSH量,利用western blot發現處理SNE能降低由aspirin所誘導的COX-2表現,綜合以上的結果,我們認為龍葵水萃物應能透過調節胃黏膜抗氧化狀態以預防aspirin誘導的胃黏膜損傷。

A recent study demonstrated that long-term use of aspirin, a none-steroidal anti-inflammatory drug (NSAID), will cause gastric mucosal damage, gastro-duodenal ulcers and complication. The cause could be due to aspirin induced reactive oxygen species (ROS) and decreased gastric mucosal antioxidant activity. We previously showed Solanum nigrum water extract (SNE) possessed antioxidative activities. In this study, we tried to detect the protective effect of SNE in aspirin inducing gastric mucosal damage. Animals were pretreated with SNE (100 mg/kg, 200 mg/kg, 400 mg/kg) for 1 hour, and then 200 mg/kg of aspirin was oral-fed to induce gastric mucosal lesions. After 4 hours, the animals were sacrificed to perform the following detections. We observed that SNE can reduce the white blood cell and the contents of malondialdehyde (MDA) in the gastric mucosa. SNE can also recover antioxidant enzyme activities such as total GST, GST Ai, GST Pi and GSH which were decreased by aspirin.
In conclusion, SNE protects aspirin-induced gastric mucosal damage could be via regulating anti-oxidative enzyme activities and reducing the damage of ROS.


壹、中文摘要.............................................1
貳、英文摘要.............................................2
參、緒論.................................................4
肆、研究動機............................................17
伍、研究架構............................................18
陸、實驗材料與方法......................................19
柒、實驗結果............................................31
捌、討論................................................36
玖、參考文獻............................................39
拾、實驗結果圖表........................................44


1.Chow,J.Y.,Ma,L.,Zhu,M.,Cho,C., H.The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterology, 1997. 113(4): p.1188-97.
2.Chan,F.K.,Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage. Eur J Gastroenterol Hepatol, 2002. 14(1): p.1-3.
3.Leung,A.M.,M.J.Redlak,and T.A. Miller,Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism. Dig Dis Sci, 2009. 54(1): p. 28-35.
4.Nair,S.,Norkus,E.P.Hertan, H. Pitchumoni, C. S.,
Micronutrient antioxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter
pylori infection affect the mucosal levels? J Clin Gastroenterol,2000. 30(4): p.381-5.
5.Naito,Y.,Yoshikawa, T.Iinuma, S. Yagi, N.et al., Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig Dis Sci, 1998. 43(9 Suppl): p.83S-89S.
6.Amann,R.and B.A. Peskar,Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol, 2002. 447(1): p.1-9.
7.Laine,L.,Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology, 2001. 120(3): p.594-606.
8.Meade,E.A.,W.L.Smith, and D.L.DeWitt, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem, 1993. 268(9): p.6610-4.
9.Gudis, K.and C.Sakamoto,The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci, 2005. 50 Suppl 1: p.S16-23.
10.Chandrasekharan, N.V.,Dai, H., Roos,K. L.,Evanson, N. K.
et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A, 2002. 99(21): p.13926-31.
11.Tanaka,A.,Araki,H.,Komoike,Y.,et al.,Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris,2001.95(1-6): p.21-7.
12.Ivey,K.J.,Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents. Am J Med,1988. 84(2A): p.41-8.
13.Aibe,T.,Fuji,T.,Okita,K.,et al.,A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography. Scand J Gastroenterol Suppl, 1986. 123: p. 6-15.
14.Yakabi,K.and T.Nakamura, Acute gastroduodenal mucosal lesion. Nippon Rinsho,1998.56(9): p.2336-42.
15.Wallace,J.L.and D.N. Granger, The cellular and molecular basis of gastric mucosal defense. Faseb J, 1996. 10(7): p. 731-40.
16.Hirose,H.,K.Takeuchi,and S.Okabe, Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology, 1991. 100(5 Pt 1): p.1259-65.
17.Whittle,B.J.,Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol,1993.110(1): p.3-17.
18.Yoshikawa,T.and M. Kondo, Free radicals in digestive diseases.Nippon Ronen Igakkai Zasshi,1990. 27(2): p. 155-60.
19.Werz,O.,D.Szellas,and D.Steinhilber, Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line. Eur J Biochem, 2000. 267(5): p.1263-9.
20.Huang,C.K.,Zhan,L,Hannigan,M.O.,et al.,P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+. J Leukoc Biol, 2000.67(2):p.210-5.
21.Shen,Y.C.,Chiou,W.F.,Chou,Y.C.,et al.,Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes.Eur J Pharmacol, 2003. 465(1-2): p.171-81.
22.Dinauer,M.C.,Disorders of neutrophil function: an overview. Methods Mol Biol, 2007. 412: p. 489-504.
23.Watanabe,T.,Arakawa,T.,Tominaga,K.,et al., Neutrophil accumulation in development gastric ulcer induced by submucosal injection of endothelin-1 in rats. Dig Dis Sci, 2000. 45(5): p.880-8.
24.Chattopadhyay,I.,Bandyopadhyay,U.,Biswas,K.,et al., Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic Biol Med, 2006. 40(8): p.1397-408.
25.Podoprigorova,V.G.,Khibin,L.S.,Kozlov,N.B.,et al., Effectiveness of synthetic antioxidants in treatment of patients with peptic ulcer (an open randomized controlled trial).Klin Med (Mosk),1999.77(3): p.32-5.
26.Galecka,E.,Mrowicka,M.,Malinowska, K.,et al., Chosen non-enzymatic substances that participate in a protection against overproduction of free radicals. Pol Merkur Lekarski, 2008.25(147): p.269-72.
27.Cadenas,E.and H. Sies,The lag phase. Free Radic Res, 1998.28(6): p.601-9.
28.Kwiecien,S.,Pawlik,M.W.,Sliwowski,Z.,et al., Involvement of sensory afferent fibers and lipid peroxidation in the pathogenesis of stress-induced gastric mucosa damage. J Physiol Pharmacol,2007.58 Suppl 3: p.149-62.
29.Valko,M.,Leibfritz, D.,Moncol, J.,et al., Free radicals and antioxidants in normal physiological functions and human disease.Int J Biochem Cell Biol,2007. 39(1): p. 44-84.
30.Hirokawa,K.and H.Kawasaki, Changes in glutathione in gastric mucosa of gastric ulcer patients. Res Commun Mol Pathol Pharmacol,1995.88(2): p.163-76.
31.Van Iersel, M.L.H. Verhagen, and P.J.van Bladeren, The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res,1999. 443(1-2): p.259-70.
32.Hayes,J.D.and D.J.Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.Crit Rev Biochem Mol Biol, 1995. 30(6): p.445-600.
33.Wang,C.,Bammler,T.K.,Guo,Y.,et al.,Mu-class GSTs are responsible for aflatoxin B(1)-8,9-epoxide-conjugating activity in the nonhuman primate macaca fascicularis liver. Toxicol Sci, 2000. 56(1): p.26-36.
34.Awasthi,S.,Srivastava,S.K.,Ahmad, F.,et al., Interactions
of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate. Biochim Biophys Acta, 1993. 1164(2): p.173-8.
35.Anttila,S.,Hirvonen,A.,Vainio, H.,et al.,
Immunohistochemical localization of glutathione S
transferases in human lung. Cancer Res,1993. 53(23): p. 5643-8.
36.Wang,G.Z.,Yin,G. L.,Zhou,G.,et al., Aspirin can elicit the recurrence of gastric ulcer induced with acetic acid in rats. Cell Physiol Biochem, 2007.20(1-4): p.205-12.
37.Steer,K.A., Wallace, T. M.,Bolton, C. H.,et al., Aspirin protects low density lipoprotein from oxidative modification. Heart,1997. 77(4): p.333-7.
38.Patrono,C.,Garcia Rodriguez, L.A.,Landolfi,R.,et al., Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med,2005.353(22): p.2373-83.
39.Fiorucci,S.,de Lima,O.M.,Jr.,Mencarelli, A.,et al., Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology, 2002. 123(5): p.1598-606.
40.Fiorucci,S.,Distrutti,E.,de Lima,O. M.,et al., Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. Faseb J, 2003. 17(9): p. 1171-3.
41.D''Argenio,G.,Mazzone,G.,Tuccillo,C.,et al.,Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa. Br J Nutr, 2008. 100(6): p.1228-36.
42.Chan, F.K.,Ching,J.Y.,Hung,L. C.,et al.,Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med, 2005. 352(3): p.238-44.
43.Scarpignato,C.and I.Pelosini, Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Ital J Gastroenterol Hepatol,1999. 31 Suppl 1: p.S63-72.
44.Yang,Y.X.,Lewis,J.D.,Epstein, S.,et al. Long-term proton pump inhibitor therapy and risk of hip fracture. Jama 2006 ; 2947-53.
45.Laheij,R.J.,Sturkenboom,M.C.,Hassing, R.J.,et al., Risk of community-acquired pneumonia and use of gastric acid-
suppressive drugs.Jama,2004.292(16): p.1955-60.
46.Berenguer,B.,Trabadela,C.,Sanchez-Fidalgo,S.,et al., The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions. J Ethnopharmacol, 2007. 114(2): p.153-60.
47.Saijo,R.,Murakami,K.,Nohara,T.,et al.,Studies on the constituents of Solanum plants.II. On the constituents of the immature berries of Solanum nigrum L. Yakugaku Zasshi, 1982. 102(3): p.300-5.
48.Sultana,S.,Perwaiz,S.,Iqbal,M.,et al.,Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. J Ethnopharmacol,1995. 45(3): p.189-92.
49.Lee,S.J.,Ko,J.H.,Lim, K.,et al.,150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacol Res, 2005. 51(5): p.399-408.
50.Lee,S.J.and K.T.Lim, 150 kDa glycoprotein isolated from Solanum nigrum Linne stimulates caspase-3 activation and reduces inducible nitric oxide production in HCT-116 cells. Toxicol In Vitro, 2006. 20(7): p. 1088-97.
51.Lin,H.M.,Tseng,H.C.,Wang, C. J.,et al., Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact, 2008. 171(3): p.283-93.
52.Berenguer,B.,Sanchez,L.M.,Quilez,A.,et al.,Protective and antioxidant effects of Rhizophora mangle L. against NSAID-induced gastric ulcers. J Ethnopharmacol, 2006. 103(2): p.194-200.
53.Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94:252- 66.
54. Harris RE, Beebe-Donk J, Doss H, Burr Doss D: Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005; 13:559-83.
55. Chan AT, Giovann ucc i E L, Meyerhardt J A, Schernhammer ES , Curhan GC , Fuchs CS : Long-term use of aspirin and nonsteroidal anti- inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294:914-23.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top